Clinical trial
Safety and Efficacy of Bronchitol in Bronchiectasis
NCT00277537 · Syntara, Industry · Completed
Key facts
| NCT number | NCT00277537 |
|---|---|
| Title | Safety and Efficacy of Bronchitol in Bronchiectasis |
| Official title | A Phase III Multicenter, Randomised, Parallel, Placebo-Controlled, Double-Blind Study to Investigate the Safety and Efficacy of Treatment With Bronchitol (Dry Powder Mannitol) in the Symptomatic Treatment of Bronchiectasis. |
| Lead sponsor | Syntara, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bronchiectasis |
| Intervention type | Drug |
| Interventions | Mannitol, placebo |
| Enrollment | 354 |
| Start date | Mar 1, 2006 |
| Primary completion | Jul 1, 2008 |
| Completion | Jul 1, 2008 |
| First posted | Jan 16, 2006 |
| Last update posted | Aug 29, 2008 |
| Countries | Australia, New Zealand, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: